IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-42672-x.html
   My bibliography  Save this article

Charge-altering releasable transporters enhance mRNA delivery in vitro and exhibit in vivo tropism

Author

Listed:
  • Zhijian Li

    (Stanford University)

  • Laura Amaya

    (Stanford University
    Stanford University School of Medicine)

  • Ruoxi Pi

    (Department of Medicine)

  • Sean K. Wang

    (Stanford University
    Stanford University School of Medicine)

  • Alok Ranjan

    (Stanford University)

  • Robert M. Waymouth

    (Stanford University)

  • Catherine A. Blish

    (Department of Medicine
    Chan Zuckerberg Biohub)

  • Howard Y. Chang

    (Stanford University
    Stanford University)

  • Paul A. Wender

    (Stanford University
    Stanford University)

Abstract

The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the development of prophylactic and therapeutic vaccines, immunotherapies for cancer and strategies for genome editing. While polymers and oligomers have served as promising mRNA delivery systems, their efficacy in hard-to-transfect cells such as primary T lymphocytes is often limited as is their cell and organ tropism. To address these problems, considerable attention has been placed on structural screening of various lipid and cation components of mRNA delivery systems. Here, we disclose a class of charge-altering releasable transporters (CARTs) that differ from previous CARTs based on their beta-amido carbonate backbone (bAC) and side chain spacing. These bAC-CARTs exhibit enhanced mRNA transfection in primary T lymphocytes in vitro and enhanced protein expression in vivo with highly selective spleen tropism, supporting their broader therapeutic use as effective polyanionic delivery systems.

Suggested Citation

  • Zhijian Li & Laura Amaya & Ruoxi Pi & Sean K. Wang & Alok Ranjan & Robert M. Waymouth & Catherine A. Blish & Howard Y. Chang & Paul A. Wender, 2023. "Charge-altering releasable transporters enhance mRNA delivery in vitro and exhibit in vivo tropism," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42672-x
    DOI: 10.1038/s41467-023-42672-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-42672-x
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-42672-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. N. N. Parayath & S. B. Stephan & A. L. Koehne & P. S. Nelson & M. T. Stephan, 2020. "In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo," Nature Communications, Nature, vol. 11(1), pages 1-17, December.
    2. Ugur Sahin & Petra Oehm & Evelyna Derhovanessian & Robert A. Jabulowsky & Mathias Vormehr & Maike Gold & Daniel Maurus & Doreen Schwarck-Kokarakis & Andreas N. Kuhn & Tana Omokoko & Lena M. Kranz & Mu, 2020. "An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma," Nature, Nature, vol. 585(7823), pages 107-112, September.
    3. Sumin Jo & Shipra Das & Alan Williams & Anne-Sophie Chretien & Thomas Pagliardini & Aude Roy & Jorge Postigo Fernandez & Diane Clerre & Billal Jahangiri & Isabelle Chion-Sotinel & Sandra Rozlan & Emil, 2022. "Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    4. Huanzhen Ni & Marine Z. C. Hatit & Kun Zhao & David Loughrey & Melissa P. Lokugamage & Hannah E. Peck & Ada Del Cid & Abinaya Muralidharan & YongTae Kim & Philip J. Santangelo & James E. Dahlman, 2022. "Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo," Nature Communications, Nature, vol. 13(1), pages 1-9, December.
    5. Wenqing Li & Xinfu Zhang & Chengxiang Zhang & Jingyue Yan & Xucheng Hou & Shi Du & Chunxi Zeng & Weiyu Zhao & Binbin Deng & David W. McComb & Yuebao Zhang & Diana D. Kang & Junan Li & William E. Carso, 2021. "Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jim Middelburg & Marjolein Sluijter & Gaby Schaap & Büşra Göynük & Katy Lloyd & Vitalijs Ovcinnikovs & Gijs G. Zom & Renoud J. Marijnissen & Christianne Groeneveldt & Lisa Griffioen & Gerwin G. W. San, 2024. "T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    2. Wojciech Barczak & Simon M. Carr & Geng Liu & Shonagh Munro & Annalisa Nicastri & Lian Ni Lee & Claire Hutchings & Nicola Ternette & Paul Klenerman & Alexander Kanapin & Anastasia Samsonova & Nicholas, 2023. "Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    3. Abigail R. Gress & Christine E. Ronayne & Joshua M. Thiede & David K. Meyerholz & Samuel Okurut & Julia Stumpf & Tailor V. Mathes & Kenneth Ssebambulidde & David B. Meya & Fiona V. Cresswell & David R, 2023. "Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    4. Wanbo Tai & Shengyong Feng & Benjie Chai & Shuaiyao Lu & Guangyu Zhao & Dong Chen & Wenhai Yu & Liting Ren & Huicheng Shi & Jing Lu & Zhuming Cai & Mujia Pang & Xu Tan & Penghua Wang & Jinzhong Lin & , 2023. "An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    5. Wanzun Lin & Li Chen & Haojiong Zhang & Xianxin Qiu & Qingting Huang & Fangzhu Wan & Ziyu Le & Shikai Geng & Anlan Zhang & Sufang Qiu & Long Chen & Lin Kong & Jiade J. Lu, 2023. "Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    6. Masahito Inagaki & Naoko Abe & Zhenmin Li & Yuko Nakashima & Susit Acharyya & Kazuya Ogawa & Daisuke Kawaguchi & Haruka Hiraoka & Ayaka Banno & Zheyu Meng & Mizuki Tada & Tatsuma Ishida & Pingxue Lyu , 2023. "Cap analogs with a hydrophobic photocleavable tag enable facile purification of fully capped mRNA with various cap structures," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    7. Jae-Hyeon Lee & Hansol Lim & Gaeun Ma & Seho Kweon & Seong Jin Park & Minho Seo & Jun-Hyuck Lee & Seong-Bin Yang & Han-Gil Jeong & Jooho Park, 2024. "Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    8. Zhaoting Li & Fanyi Mo & Yixin Wang & Wen Li & Yu Chen & Jun Liu & Ting-Jing Chen-Mayfield & Quanyin Hu, 2022. "Enhancing Gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    9. Matthew T.J. Halma & Jessica Rose & Theresa Lawrie, 2023. "The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review," J, MDPI, vol. 6(2), pages 1-16, April.
    10. Emily K. Ninmer & Hong Zhu & Kimberly A. Chianese-Bullock & Margaret Mehren & Naomi B. Haas & Merrick I. Ross & Lynn T. Dengel & Craig L. Slingluff, 2024. "Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    11. Lulu Xue & Alex G. Hamilton & Gan Zhao & Zebin Xiao & Rakan El-Mayta & Xuexiang Han & Ningqiang Gong & Xinhong Xiong & Junchao Xu & Christian G. Figueroa-Espada & Sarah J. Shepherd & Alvin J. Mukalel , 2024. "High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models," Nature Communications, Nature, vol. 15(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42672-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.